UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000034954
Receipt No. R000039856
Scientific Title Phase 1/2a, Double-blind, Placebo-controlled Study with an Open-label Extension of Ropinirole Hydrochloride Extended-Release Tablets -Explorative Assessment of the Safety, Tolerability, and Efficacy after Oral Treatment in Patients with Amyotrophic Lateral Sclerosis (ALS)-
Date of disclosure of the study information 2018/11/30
Last modified on 2019/09/13 06:53:26

No. Disposal Last modified on Item of update
1 Insert 2018/11/20 23:41:27
2 Update 2018/11/20 23:42:09 UMIN ID1
3 Update 2019/04/17 21:55:33 Recruitment status
Date of IRB
Last follow-up date
4 Update 2019/05/26 21:41:05 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Organization
Organization
Address
Address
Tel
Email
5 Update 2019/09/13 06:50:57 Recruitment status
6 Update 2019/09/13 06:53:26 Number of participants that the trial has enrolled


Contact us.